-
Funding Data from Publication Acknowledgements: Coverage, Uses and Limitations
Authors:
Nicola Grassano,
Daniele Rotolo,
Josh Hutton,
Frédérique Lang,
Michael M. Hopkins
Abstract:
This article contributes to the development of methods for analysing research funding systems by exploring the robustness and comparability of emerging approaches to generate funding landscapes useful for policy making. We use a novel dataset of manually extracted and coded data on the funding acknowledgements of 7,510 publications representing UK cancer research in the year 2011 and compare these…
▽ More
This article contributes to the development of methods for analysing research funding systems by exploring the robustness and comparability of emerging approaches to generate funding landscapes useful for policy making. We use a novel dataset of manually extracted and coded data on the funding acknowledgements of 7,510 publications representing UK cancer research in the year 2011 and compare these 'reference data' with funding data provided by Web of Science (WoS) and MEDLINE/PubMed. Findings show high recall (about 93%) of WoS funding data. By contrast, MEDLINE/PubMed data retrieved less than half of the UK cancer publications acknowledging at least one funder. Conversely, both databases have high precision (+90%): i.e. few cases of publications with no acknowledgement to funders are identified as having funding data. Nonetheless, funders acknowledged in UK cancer publications were not correctly listed by MEDLINE/PubMed and WoS in about 75% and 32% of the cases, respectively. 'Reference data' on the UK cancer research funding system are then used as a case-study to demonstrate the utility of funding data for strategic intelligence applications (e.g. map** of funding landscape, comparison of funders' research portfolios).
△ Less
Submitted 17 April, 2016;
originally announced April 2016.
-
A Triple Helix Model of Medical Innovation: Supply, Demand, and Technological Capabilities in terms of Medical Subject Headings
Authors:
Alexander M. Petersen,
Daniele Rotolo,
Loet Leydesdorff
Abstract:
We develop a model of innovation that enables us to trace the interplay among three key dimensions of the innovation process: (i) demand of and (ii) supply for innovation, and (iii) technological capabilities available to generate innovation in the forms of products, processes, and services. Building on triple helix research, we use entropy statistics to elaborate an indicator of mutual informatio…
▽ More
We develop a model of innovation that enables us to trace the interplay among three key dimensions of the innovation process: (i) demand of and (ii) supply for innovation, and (iii) technological capabilities available to generate innovation in the forms of products, processes, and services. Building on triple helix research, we use entropy statistics to elaborate an indicator of mutual information among these dimensions that can provide indication of reduction of uncertainty. To do so, we focus on the medical context, where uncertainty poses significant challenges to the governance of innovation. We use the Medical Subject Headings (MeSH) of MEDLINE/PubMed to identify publications classified within the categories "Diseases" (C), "Drugs and Chemicals" (D), "Analytic, Diagnostic, and Therapeutic Techniques and Equipment" (E) and use these as knowledge representations of demand, supply, and technological capabilities, respectively. Three case-studies of medical research areas are used as representative 'entry perspectives' of the medical innovation process. These are: (i) human papilloma virus, (ii) RNA interference, and (iii) magnetic resonance imaging. We find statistically significant periods of synergy among demand, supply, and technological capabilities (C-D-E) that point to three-dimensional interactions as a fundamental perspective for the understanding and governance of the uncertainty associated with medical innovation. Among the pairwise configurations in these contexts, the demand-technological capabilities (C-E) provided the strongest link, followed by the supply-demand (D-C) and the supply-technological capabilities (D-E) channels.
△ Less
Submitted 4 January, 2016; v1 submitted 22 December, 2015;
originally announced December 2015.
-
What Is an Emerging Technology?
Authors:
Daniele Rotolo,
Diana Hicks,
Ben R. Martin
Abstract:
There is considerable and growing interest in the emergence of novel technologies, especially from the policy-making perspective. Yet as an area of study, emerging technologies lacks key foundational elements, namely a consensus on what classifies a technology as 'emergent' and strong research designs that operationalize central theoretical concepts. The present paper aims to fill this gap by deve…
▽ More
There is considerable and growing interest in the emergence of novel technologies, especially from the policy-making perspective. Yet as an area of study, emerging technologies lacks key foundational elements, namely a consensus on what classifies a technology as 'emergent' and strong research designs that operationalize central theoretical concepts. The present paper aims to fill this gap by develo** a definition of 'emerging technologies' and linking this conceptual effort with the development of a framework for the operationalisation of technological emergence. The definition is developed by combining a basic understanding of the term and in particular the concept of 'emergence' with a review of key innovation studies dealing with definitional issues of technological emergence. The resulting definition identifies five attributes that feature in the emergence of novel technologies. These are: (i) radical novelty, (ii) relatively fast growth, (iii) coherence, (iv) prominent impact, and (v) uncertainty and ambiguity. The framework for operationalising emerging technologies is then elaborated on the basis of the proposed attributes. To do so, we identify and review major empirical approaches (mainly in, although not limited to, the scientometric domain) for the detection and study of emerging technologies (these include indicators and trend analysis, citation analysis, co-word analysis, overlay map**, and combinations thereof) and elaborate on how these can be used to operationalise the different attributes of emergence.
△ Less
Submitted 4 January, 2016; v1 submitted 13 February, 2015;
originally announced March 2015.
-
Journal Portfolio Analysis for Countries, Cities, and Organizations: Maps and Comparisons
Authors:
Loet Leydesdorff,
Gaston Heimeriks,
Daniele Rotolo
Abstract:
Using Web-of-Science data, portfolio analysis in terms of journal coverage can be projected on a base map for units of analysis such as countries, cities, universities, and firms. The units of analysis under study can be compared statistically across the 10,000+ journals. The interdisciplinarity of the portfolios is measured using Rao-Stirling diversity or Zhang et al.'s (in press) improved measur…
▽ More
Using Web-of-Science data, portfolio analysis in terms of journal coverage can be projected on a base map for units of analysis such as countries, cities, universities, and firms. The units of analysis under study can be compared statistically across the 10,000+ journals. The interdisciplinarity of the portfolios is measured using Rao-Stirling diversity or Zhang et al.'s (in press) improved measure 2D3. At the country level we find regional differentiation (e.g., Latin-American or Asian countries), but also a major divide between advanced and less-developed countries. Israel and Israeli cities outperform other nations and cities in terms of diversity. Universities appear to be specifically related to firms when a number of these units are exploratively compared. The instrument is relatively simple and straightforward, and one can generalize the application to any document set retrieved from WoS. Further instruction is provided online at http://www.leydesdorff.net/portfolio .
△ Less
Submitted 24 April, 2015; v1 submitted 19 February, 2015;
originally announced February 2015.
-
Matching MEDLINE/PubMed Data with Web of Science (WoS): A Routine in R language
Authors:
Daniele Rotolo,
Loet Leydesdorff
Abstract:
We present a novel routine, namely medlineR, based on R-language, that enables the user to match data from MEDLINE/PubMed with records indexed in the ISI Web of Science (WoS) database. The matching allows exploiting the rich and controlled vocabulary of Medical Subject Headings (MeSH) of MEDLINE/PubMed with additional fields of WoS. The integration provides data (e.g. citation data, list of cited…
▽ More
We present a novel routine, namely medlineR, based on R-language, that enables the user to match data from MEDLINE/PubMed with records indexed in the ISI Web of Science (WoS) database. The matching allows exploiting the rich and controlled vocabulary of Medical Subject Headings (MeSH) of MEDLINE/PubMed with additional fields of WoS. The integration provides data (e.g. citation data, list of cited reference, full list of the addresses of authors' host organisations, WoS subject categories) to perform a variety of scientometric analyses. This brief communication describes medlineR, the methodology on which it relies, and the steps the user should follow to perform the matching across the two databases. In order to specify the differences from Leydesdorff and Opthof (2013), we conclude the brief communication by testing the routine on the case of the "Burgada Syndrome".
△ Less
Submitted 10 July, 2014; v1 submitted 16 June, 2014;
originally announced June 2014.
-
Determinants of Patent Citations in Biotechnology: An Analysis of Patent Influence Across the Industrial and Organizational Boundaries
Authors:
Antonio Messeni Petruzzelli,
Daniele Rotolo,
Vito Albino
Abstract:
The present paper extends the literature investigating key drivers leading certain patents to exert a stronger influence on the subsequent technological developments (inventions) than other ones. We investigated six key determinants, as (i) the use of scientific knowledge, (ii) the breadth of the technological base, (iii) the existence of collaboration in patent development, (iv) the number of cla…
▽ More
The present paper extends the literature investigating key drivers leading certain patents to exert a stronger influence on the subsequent technological developments (inventions) than other ones. We investigated six key determinants, as (i) the use of scientific knowledge, (ii) the breadth of the technological base, (iii) the existence of collaboration in patent development, (iv) the number of claims, (v) the scope, and (vi) the novelty, and how the effect of these determinants varies when patent influence - as measured by the number of forward citations the patent received - is distinguished as within and across the industrial and organizational boundaries. We conducted an empirical analysis on a sample of 5671 patents granted to 293 US biotechnology firms from 1976 to 2003. Results reveal that the contribution of the determinants to patent influence differs across the domains that are identified by the industrial and organizational boundaries. Findings, for example, show that the use of scientific knowledge negatively affects patent influence outside the biotechnology industry, while it positively contributes to make a patent more relevant for the assignee's subsequent technological developments. In addition, the broader the scope of a patent the higher the number of citations the patent receives from subsequent non-biotechnology patents. This relationship is inverted-U shaped when considering the influence of a patent on inventions granted to other organizations than the patent's assignee. Finally, the novelty of a patent is inverted-U related with the influence the patent exerts on the subsequent inventions granted across the industrial and organizational boundaries.
△ Less
Submitted 9 March, 2014;
originally announced March 2014.
-
Strategic Intelligence on Emerging Technologies: Scientometric Overlay Map**
Authors:
Daniele Rotolo,
Ismael Rafols,
Michael Hopkins,
Loet Leydesdorff
Abstract:
This paper examines the use of scientometric overlay map** as a tool of 'strategic intelligence' to aid the governance of emerging technologies. We develop an integrative synthesis of different overlay map** techniques and associated perspectives on technological emergence across the geographical, social, and cognitive spaces. To do so, we longitudinally analyse (with publication and patent da…
▽ More
This paper examines the use of scientometric overlay map** as a tool of 'strategic intelligence' to aid the governance of emerging technologies. We develop an integrative synthesis of different overlay map** techniques and associated perspectives on technological emergence across the geographical, social, and cognitive spaces. To do so, we longitudinally analyse (with publication and patent data) three case-studies of emerging technologies in the medical domain. These are: RNA interference (RNAi), Human Papilloma Virus (HPV) testing technologies for cervical cancer, and Thiopurine Methyltransferase (TPMT) genetic testing. Given the flexibility (i.e. adaptability to different sources of data) and granularity (i.e. applicability across multiple levels of data aggregation) of overlay map** techniques, we argue that these techniques can favour the integration and comparison of results from different contexts and cases, thus potentially functioning as platform for a 'distributed' strategic intelligence for analysts and decision-makers.
△ Less
Submitted 7 September, 2015; v1 submitted 19 March, 2013;
originally announced March 2013.
-
Bibliometric Perspectives on Medical Innovation using the Medical Subject Headings (MeSH) of PubMed
Authors:
Loet Leydesdorff,
Daniele Rotolo,
Ismael Rafols
Abstract:
Multiple perspectives on the nonlinear processes of medical innovations can be distinguished and combined using the Medical Subject Headings (MeSH) of the Medline database. Focusing on three main branches-"diseases," "drugs and chemicals," and "techniques and equipment"-we use base maps and overlay techniques to investigate the translations and interactions and thus to gain a bibliometric perspect…
▽ More
Multiple perspectives on the nonlinear processes of medical innovations can be distinguished and combined using the Medical Subject Headings (MeSH) of the Medline database. Focusing on three main branches-"diseases," "drugs and chemicals," and "techniques and equipment"-we use base maps and overlay techniques to investigate the translations and interactions and thus to gain a bibliometric perspective on the dynamics of medical innovations. To this end, we first analyze the Medline database, the MeSH index tree, and the various options for a static map** from different perspectives and at different levels of aggregation. Following a specific innovation (RNA interference) over time, the notion of a trajectory which leaves a signature in the database is elaborated. Can the detailed index terms describing the dynamics of research be used to predict the diffusion dynamics of research results? Possibilities are specified for further integration between the Medline database, on the one hand, and the Science Citation Index and Scopus (containing citation information), on the other.
△ Less
Submitted 7 April, 2012; v1 submitted 5 March, 2012;
originally announced March 2012.
-
Innovation as a Nonlinear Process, the Scientometric Perspective, and the Specification of an "Innovation Opportunities Explorer"
Authors:
Loet Leydesdorff,
Daniele Rotolo,
Wouter de Nooy
Abstract:
The process of innovation follows non-linear patterns across the domains of science, technology, and the economy. Novel bibliometric map** techniques can be used to investigate and represent distinctive, but complementary perspectives on the innovation process (e.g., "demand" and "supply") as well as the interactions among these perspectives. The perspectives can be represented as "continents" o…
▽ More
The process of innovation follows non-linear patterns across the domains of science, technology, and the economy. Novel bibliometric map** techniques can be used to investigate and represent distinctive, but complementary perspectives on the innovation process (e.g., "demand" and "supply") as well as the interactions among these perspectives. The perspectives can be represented as "continents" of data related to varying extents over time. For example, the different branches of Medical Subject Headings (MeSH) in the Medline database provide sources of such perspectives (e.g., "Diseases" versus "Drugs and Chemicals"). The multiple-perspective approach enables us to reconstruct facets of the dynamics of innovation, in terms of selection mechanisms sha** localizable trajectories and/or resulting in more globalized regimes. By expanding the data with patents and scholarly publications, we demonstrate the use of this multi-perspective approach in the case of RNA Interference (RNAi). The possibility to develop an "Innovation Opportunities Explorer" is specified.
△ Less
Submitted 29 January, 2013; v1 submitted 28 February, 2012;
originally announced February 2012.
